@erogul1 @mkaeberlein @William_Mair @LammingLab @AdamsBioAging Agree about caution in children Rapamycin (sirolimus) is used for more than a decade to treat children with TSC. But we cannot deduct how rapamycin affects growth etc because mTOR activity is a
Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis | Orphanet Journal of Rare Diseases | Full Text https://t.co/Z8ih5uzmi8
RT @GrupoOrpharSEFH: Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis h…
RT @GrupoOrpharSEFH: Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis h…
Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis https://t.co/cXDQBOJ79i
RT @ojrarediseases: A new review on the efficacy and safety of mTOR inhibitors for tuberous sclerosis complex #TSC #RareDisease https://t…
Attn @dravetCanada
A new review on the efficacy and safety of mTOR inhibitors for tuberous sclerosis complex #TSC #RareDisease https://t.co/BQiHDmeeNx